Raymond Woo's most recent trade in Ceribell Inc. was a trade of 4,887 shares done at an average price of $24.4 . Disclosure was reported to the exchange on Oct. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 01 Oct 2026 | 4,887 | 203,118 | - | 24.4 | 119,145 | - |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.65 per share. | 01 Oct 2026 | 4,864 | 207,982 | - | 3.7 | 17,754 | - |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Oct 2026 | 23 | 208,005 | - | 4.7 | 108 | - |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 08 Sep 2026 | 8,389 | 0 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 08 Sep 2026 | 8,389 | 203,118 | - | 2.2 | 18,791 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.33 per share. | 08 Sep 2026 | 4,887 | 203,118 | - | 24.3 | 118,901 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.65 per share. | 08 Sep 2026 | 4,864 | 207,982 | - | 3.7 | 17,754 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 08 Sep 2026 | 4,864 | 53,501 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 08 Sep 2026 | 23 | 208,005 | - | 4.7 | 108 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 08 Sep 2026 | 23 | 19,044 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 21 Aug 2026 | 1,979 | 194,729 | - | 24.0 | 47,536 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 21 May 2026 | 1,966 | 195,682 | - | 18 | 35,388 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 May 2026 | 6,611 | 19,067 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.45 per share. | 01 May 2026 | 6,611 | 197,648 | - | 20.5 | 135,195 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 May 2026 | 6,611 | 204,259 | - | 4.7 | 31,072 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 May 2026 | 3,024 | 32,697 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.43 per share. | 01 May 2026 | 3,024 | 197,648 | - | 20.4 | 61,780 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 May 2026 | 3,024 | 200,672 | - | 4.7 | 14,213 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 01 May 2026 | 1,469 | 199,117 | - | 2.2 | 3,291 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 May 2026 | 1,469 | 8,389 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 01 May 2026 | 1,469 | 197,648 | - | 20.4 | 29,953 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Apr 2026 | 51,227 | 51,227 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 30,736 | 197,648 | - | 0 | Common Stock | |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Apr 2026 | 6,615 | 25,678 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.57 per share. | 01 Apr 2026 | 6,615 | 166,912 | - | 18.6 | 122,841 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Apr 2026 | 6,615 | 173,527 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Apr 2026 | 3,025 | 35,721 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.53 per share. | 01 Apr 2026 | 3,025 | 166,912 | - | 18.5 | 56,053 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Apr 2026 | 3,025 | 169,937 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 01 Apr 2026 | 1,472 | 168,384 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Apr 2026 | 1,472 | 9,858 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.58 per share. | 01 Apr 2026 | 1,472 | 166,912 | - | 18.6 | 27,350 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Mar 2026 | 6,615 | 32,293 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.25 per share. | 02 Mar 2026 | 6,615 | 166,912 | - | 18.3 | 120,724 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Mar 2026 | 6,615 | 173,527 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 02 Mar 2026 | 3,025 | 166,912 | - | 18.3 | 55,237 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Mar 2026 | 3,025 | 169,937 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Mar 2026 | 3,025 | 38,746 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 02 Mar 2026 | 1,472 | 166,912 | - | 18.3 | 26,879 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 02 Mar 2026 | 1,472 | 168,384 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Mar 2026 | 1,472 | 11,330 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 19.79 per share. | 23 Feb 2026 | 705 | 166,912 | - | 19.8 | 13,952 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.54 per share. | 02 Feb 2026 | 6,615 | 167,617 | - | 20.5 | 135,872 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Feb 2026 | 6,615 | 38,908 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Feb 2026 | 6,615 | 174,232 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Feb 2026 | 3,025 | 41,771 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Feb 2026 | 3,025 | 170,642 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.57 per share. | 02 Feb 2026 | 3,025 | 167,617 | - | 20.6 | 62,224 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Feb 2026 | 1,472 | 12,802 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 02 Feb 2026 | 1,472 | 169,089 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.57 per share. | 02 Feb 2026 | 1,472 | 167,617 | - | 20.6 | 30,279 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.28 per share. | 01 Dec 2025 | 11,112 | 167,704 | - | 12.3 | 136,455 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Dec 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Dec 2025 | 6,615 | 52,138 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Dec 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Dec 2025 | 3,025 | 47,821 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 01 Dec 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Dec 2025 | 1,472 | 15,746 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 20 Nov 2025 | 6,615 | 173,932 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 20 Nov 2025 | 6,615 | 45,523 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 21.16 per share. | 20 Nov 2025 | 6,615 | 167,317 | - | 21.2 | 139,973 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 21.18 per share. | 20 Nov 2025 | 3,025 | 167,317 | - | 21.2 | 64,070 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 20 Nov 2025 | 3,025 | 170,342 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 20 Nov 2025 | 3,025 | 44,796 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 20 Nov 2025 | 1,472 | 14,274 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 20 Nov 2025 | 1,472 | 168,789 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 21.29 per share. | 20 Nov 2025 | 1,472 | 167,317 | - | 21.3 | 31,339 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.64 per share. | 20 Nov 2025 | 687 | 167,317 | - | 13.6 | 9,371 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.28 per share. | 11 Nov 2025 | 11,112 | 167,704 | - | 12.3 | 136,455 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 11 Nov 2025 | 6,615 | 58,753 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 11 Nov 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 11 Nov 2025 | 3,025 | 50,846 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 11 Nov 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 11 Nov 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 11 Nov 2025 | 1,472 | 17,218 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.54 per share. | 03 Oct 2025 | 11,112 | 167,704 | - | 12.5 | 139,344 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 03 Oct 2025 | 6,615 | 65,368 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 03 Oct 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 03 Oct 2025 | 3,025 | 53,871 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 03 Oct 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 03 Oct 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 03 Oct 2025 | 1,472 | 18,690 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.11 per share. | 04 Sep 2025 | 11,112 | 167,704 | - | 12.1 | 134,566 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 04 Sep 2025 | 6,615 | 71,983 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 04 Sep 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 04 Sep 2025 | 3,025 | 56,896 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 04 Sep 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 04 Sep 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 04 Sep 2025 | 1,472 | 20,162 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 02 Sep 2025 | 20,000 | 21,634 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 02 Sep 2025 | 20,000 | 167,704 | - | 2.2 | 44,800 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.58 per share. | 25 Aug 2025 | 687 | 147,704 | - | 11.6 | 7,955 | Common Stock |
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | 01 Apr 2025 | 51,159 | 51,159 | - | - | Stock Option (Right to Buy) | ||
| Ceribell Inc | Dr. Raymond Woo, PhD | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 30,695 | 148,391 | - | 0 | Common Stock | |
| Oruka Therapeutics Inc | Raymond Woosley L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| DoubleLine Opportunistic Credit Fund | Mr. Raymond B. Woolson | Trustee | 29 Dec 2023 | 5,291 | 0 | - | - | Common Shares | ||
| Doubleline Income Soln Fund | Mr. Raymond B. Woolson | Trustee | 29 Dec 2023 | 3,659 | 0 | - | - | Common Shares | ||
| DoubleLine Yield Opportunities Fund | Mr. Raymond B. Woolson | Trustee | 29 Dec 2023 | 1,776 | 0 | - | - | Common Shares | ||
| Oruka Therapeutics Inc | Raymond L. Woosley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Westwood Holdings Grp Inc | Mr. Raymond E. Wooldridge | Director | Purchase of securities on an exchange or from another person at price $ 17.49 per share. | 01 Nov 2021 | 10,000 | 77,597 (0%) | 0% | 17.5 | 174,887 | common stock |